NCT06618196
Study to Evaluate the Immunogenicity of LR20062 Compared to Control When Administered Intramuscularly in Healthy Infants At 2, 4, 6 Months of Age No drug interventions prevention 2 not_yet_recruiting NCT06605755
Safety and Immunogenicity of DTaP-IPV/Hib Pentavalent Vaccine in Chinese 2-month-old Infants No drug interventions prevention Not Available recruiting NCT01031303
Immunogenicity and Safety of TETRAXIM™ Given as a Booster Dose at 4 to 6 Years of Age prevention 4 completed NCT02946190
The PertADO Geneva Trial prevention 2 completed NCT03908164
Optimising the Timing of Whooping Cough Immunisation in MUMs No drug interventions prevention 4 unknown_status NCT00355121
Study of Menactra® in Children Aged 4 to 6 Years When Administered Concomitantly With a Fifth Dose of DAPTACEL® prevention 2 completed NCT00343421
Study to Compare Pediacel® to Infanrix®-IPV+Hib When Both Are Co-Administered With Prevenar® in Infants and Toddlers prevention 3 completed NCT00255021
Immunogenicity and Safety of Sanofi Pasteur Pentaxim Combined Vaccine in Infants in Thailand prevention 4 completed NCT02301702
Maternal Tdap Immunization in Guatemala prevention 2 completed NCT00619502
Study of Immunogenicity and Safety of a Booster Dose of DTaP-IPV-HB-PRP~T Combined Vaccine in Healthy Turkish Infants No drug interventions prevention 3 completed NCT01470287
Immunogenicity, Safety and Tolerability of a Fully Liquid Pentavalent (DTwP-Hib-Hep B) Vaccine in Infants 6-8 Weeks of Age No drug interventions prevention 3 completed NCT01491087
Safety of PENTAXIM® Given as a Three-Dose Primary Vaccination at 2, 3, and 4 Months of Age in Infants in China prevention 4 completed NCT01597687
Pertussis Infection in Adolescents and Adults With Prolonged Cough No drug interventions other Not Available completed NCT00534833
Immunogenicity Study of Antibody Persistence and Booster Effect of DTaP-HB-PRP~T Combined Vaccine or Tritanrix-HepB/Hib™ prevention 3 completed NCT02094833
DTaP-IPV-Hep B-PRP~T Combined Vaccine Versus DTaP-IPV//PRP~T Combined Vaccine + Hep B Vaccine in Hep B Primed Infants prevention 3 completed NCT02817451
DTaP-IPV-HB-PRP-T Combined Vaccine as a Primary Series and a Second Year of Life Booster in HIV-Exposed Infected and Uninfected Infants prevention 3 completed NCT00319553
Post-licensure, Modified Double-blind, Multi-center Study Evaluating Safety and Immunogenicity of ADACEL® and BOOSTRIX® prevention 4 completed NCT01062477
A Study of DTaP//PRP-T Combined Vaccine (ACTACEL) Versus Local DTaP and Act-HIB Monovalent Vaccine in Healthy Infants prevention 3 completed NCT00255047
Safety and Immune Response of Different Pediatric Combination Vaccines. prevention 3 completed NCT00168545
Immunology of Non-specific Effects of Vaccine diagnostic 4 completed NCT02257645
Post-authorization Safety Study of Euforvac-Hib Vaccine for Active Primary Immunization in Infants From 6 Weeks No drug interventions Not Available Not Available unknown_status NCT03147898
Observational Study Describing the Immune Profile Induced By Pertussis Vaccines No drug interventions Not Available Not Available completed NCT01249183
Safety and Immunogenicity Study of Concomitant Versus Non Concomitant Administration of a Diphtheria, Tetanus, Pertussis and Poliomyelitis Vaccine (REPEVAX) and Influenza Vaccine (VAXIGRIP) in Subjects Aged From 60 Years Old prevention 3 completed NCT02458183
Vaccine -diphthEria -tetaNus -Acellular pertUssis-inactivated polioviruS No drug interventions prevention 3 completed NCT03870061
Evaluation of an Infant Immunization Encouragement Program in Nigeria No drug interventions prevention Not Available completed NCT02118961
Study of BK1301 (DTaP Vaccine) as a Booster in Adolescents prevention 3 completed NCT04056728
A Phase IV Study to Assess the Safety of EupentaTM Inj No drug interventions prevention 4 unknown_status NCT02274285
DTaP-IPV/Hib Vaccine Primary & Booster Vaccinations Versus Co-administration of DTaP-IPV and Hib Vaccine in Japanese Infants No drug interventions prevention 3 completed NCT00336115
The Safety and Immunogenicity of Acellular Pertussis Vaccine in Bone Marrow Transplant Recipients prevention 4 unknown_status NCT04102137
3-year Follow-up After a Single Dose Acellular Pertussis Vaccination Not Available Not Available completed NCT00524732
Assessment of the Reactogenicity of ADACEL® (TdcP Vaccine) in Children and Adolescents 7 to 19 Years of Age Not Available Not Available completed NCT03982732
Maternal Antibody in Milk After Vaccination Not Available Not Available unknown_status NCT00319852
Immunogenicity and Safety of Tetraxim Versus Local DTP + IPV prevention 3 completed NCT01040052
A Study to Assess the Safety of Adacel® Vaccine prevention 3 completed NCT03498300
Seroprevalence of Bordetella Pertussis Antibodies and Anti-pertussis Antibody Response After a Single Dose of Tdap in Pregnant Thai Women No drug interventions prevention 0 completed NCT00712959
Immune Responses in Adults to Revaccination With ADACEL® 10 Years After a Previous Dose prevention 4 completed NCT04073459
Safety and Immunogenicity of Hexavalent Vaccine(DTwP-HepB-IPV-Hib) in Healthy Infants No drug interventions prevention 2 unknown_status NCT03304275
The Feasibility of Pertussis Immunization in a Canadian Emergency Department No drug interventions health_services_research Not Available completed NCT00453570
Immunogenicity and Safety of Pentaxim as 3 Doses Primary Vaccination Followed by a Booster Dose at 18 Months prevention 3 completed NCT00432042
Immunogenicity and Safety Study of Proquad® and Infanrix® Hexa When Administered Concomitantly (V221-035) prevention 3 completed NCT06184542
Phase I Clinical Trial of Diphtheria-Tetanus-acellular Pertussis Component Combined Vaccine prevention 1 recruiting NCT05136599
Establishing a Controlled Human Infection Model of Bordetella Pertussis other 1 active_not_recruiting NCT03541499
Safety and Immunogenicity of Intranasal BPZE1 Vaccination in Healthy Adults No drug interventions prevention 2 completed NCT00004799
Phase III Randomized, Double-Blind, Placebo-Controlled Study of Acellular and Whole-Cell Pertussis Vaccines prevention 3 completed NCT00457249
A Trial to Evaluate the Safety and Immunogenicity of ADACEL® Vaccine in Persons 65 Years of Age and Older prevention 4 completed NCT02040636
Study of Tetanus and Diphtheria Toxoids Adsorbed Combined With Component Pertussis Vaccine and Inactivated Poliomyelitis prevention 2 completed NCT02382913
Persistency Study After aP / Tdap Booster Vaccines in Adult Subjects (V113_01 Extension 1) Not Available 1 completed NCT00467519
Safety and Immunogenicity of Tdap Vaccine Compared to DTaP Vaccine in Children 4 to 6 Years of Age prevention 3 completed NCT01706224
Sero-prevalence of Anti-pertussis Antibodies and Disease Awareness Among Spanish Healthcare Professionals No drug interventions Not Available Not Available completed NCT00303316
Immunogenicity Study of Antibody Persistence and Booster Effect of PENTAXIM™ at 18 Months in Healthy Argentinean Infants prevention 3 completed NCT01659996
Study of Menactra® in Healthy Subjects at 9 Months and Concomitantly With Pentacel® at 15 to 18 Months of Age prevention 4 completed NCT03606096
Gambia Pertussis Study (GaPs) prevention 4 unknown_status NCT01267058
Booster Study of Combined Diphtheria-tetanus-acellular Pertussis Vaccine in Healthy Adults prevention 3 completed NCT00347958
Descriptive, Open-label, Multicenter Study of the Safety of Redosing With ADACEL® Vaccine prevention 4 completed NCT03891758
Confirmatory Study of BK1310 in Healthy Infants prevention 3 completed NCT04694963
A Multi-center Study to Determine the Prevalence and Influence of Pertussis on Subacute Cough in Shenzhen No drug interventions Not Available Not Available unknown_status NCT03931239
The Transparent Safety Study of the 5 in 1 (DTwP-rHepB-Hib) Combination Vaccine Produced by the Indian Serine Institute in Children of Viet Nam Healthy From 6 to 12 Weeks of Age in a 3-dose Regimen, the Interval Between Doses is 4 Weeks No drug interventions prevention Not Available completed NCT00707148
Pertussis Vaccine in Healthy Pregnant Women prevention 1 completed NCT02453048
Study of BPZE1 (High Dose) Nasal Live Attenuated B. Pertussis Vaccine No drug interventions prevention 1 completed NCT01311557
Study of Adacel® Vaccine Administered to Persons 10 Years of Age prevention 4 completed NCT00777257
Study of Menactra® in US Adolescents When Administered Concomitantly With Tdap Vaccine prevention 4 completed NCT03909126
Pertussis Vaccination in Pregnant Women prevention 4 completed NCT02408926
Vaccine Responses in Infants After Acellular Pertussis Vaccination During Pregnancy in Thailand prevention 4 completed NCT00304265
Post-marketing Evaluation of Reactions Following Receipt of Recommended Adolescent Pertussis Vaccine No drug interventions prevention 4 completed NCT04529720
5-year Follow-up After a Single Dose Acellular Pertussis Vaccination Not Available Not Available completed NCT01357720
Study to Assess if Quinvaxem Can be Interchanged With Other Pentavalent Vaccines During Standard Childhood Vaccination No drug interventions prevention 4 completed NCT04793620
Pertussis Acellular Vaccine Adjuvanted With TQL1055 prevention 1 terminated NCT00258882
Descriptive, Post-marketing, Passive Surveillance Safety Study of ADACEL™ Vaccine Not Available Not Available completed NCT00401531
Comparison of a DTaP-IPV-HB-PRP~T Combined Vaccine to Infanrix™-Hexa, When Administered With Prevnar® in Thai Infants prevention 3 completed NCT03519373
Pertussis Immunization During Pregnancy & HIV Infection No drug interventions Not Available Not Available completed NCT02096276
Boostrix® Pregnancy Registry No drug interventions Not Available Not Available completed NCT01933776
Study of the Tdap Combined Vaccine (ADACEL™) as a Booster Dose in Healthy Adults and Children in China prevention 1 completed NCT06114160
Knowledge of Pregnant Women Concerning Pertussis, Vaccination Against Pertussis and Cocooning Strategy No drug interventions Not Available Not Available not_yet_recruiting NCT02526394
Pertussis and Meningitis C Concomitant Vaccination in Adolescents treatment 4 completed NCT00518180
A Study to Evaluate Safety and Immune Response of Novartis Meningococcal ACWY Conjugate Vaccine In Adolescents No drug interventions prevention 3 completed NCT01629589
Immunogenicity of Adacel® and BOOSTRIX® Vaccines in Adolescents prevention 4 completed NCT00343889
Comparison of DTaP-HB-PRP~T Combined Vaccine to Tritanrix-HepB/Hib™, Both Given Concomitantly With Oral Polio Vaccine prevention 3 completed NCT00287092
Comparison of Safety and Immunogenicity of Pediacel™ and Infanrix™ IPV+Hib (Penta) Given in a 3 Dose Schedule in Infants prevention 3 completed NCT02858440
A Study to Assess the Immunogenicity and Safety of GSK Biologicals' Infanrix-IPV/Hib Vaccine Administered as a Three-dose Vaccination Course at 3, 4.5 and 6 Months of Age and a Booster Dose at 18 Months of Age in Healthy Infants in Russia prevention 3 completed NCT00802867
Study of DAPTACEL® Administered as a 5th Dose in 4 to 6-Year-Old Children Previously Immunized With PENTACEL™ prevention 4 completed NCT00291967
Assess Immune Response Following Primary Vaccination With Tritanrix™-HepB Vaccine Mixed With 3 Formulations of Hib-MenAC Vaccine to Infants No drug interventions prevention 2 completed NCT00654901
Study of the DTaP-IPV-Hep B-PRP~T Combined Vaccine Following a Primary Series of DTacP IPV-HepB-PRP-T or Infanrix Hexa™ prevention 3 completed NCT01233401
Tdap Vaccination for Infant Caregivers No drug interventions Not Available Not Available completed NCT00932269
Seroimmunity 2007 and Sub Study of the Swedish Population Regarding Vaccine Preventable Disease No drug interventions Not Available Not Available unknown_status NCT04543669
Adacel® Booster Vaccination for CMI Assay Development prevention 4 completed NCT00254969
Immunogenicity and Safety of Pentaxim in South African Infants prevention 3 completed NCT05457946
Study to Evaluate the Immunogenicity and Safety of LBVD(Hexavalent Vaccine), Given to Healthy Infants at Primary Series No drug interventions prevention 2 / 3 not_yet_recruiting NCT00617812
Safety and Immunogenicity Study of a Liquid Pentavalent Combination Vaccine No drug interventions prevention 4 completed NCT01188512
First Adult Safety Trial on Nasal Live Attenuated B. Pertussis Vaccine No drug interventions prevention 1 completed NCT00348881
Study Comparing a DTaP-HB-PRP~T Combined Vaccine With Tritanrix HepB/Hib™, Concomitantly With OPV in Healthy Infants No drug interventions prevention 3 completed NCT00258895
Safety and Immunogenicity of DAPTACEL® as 5th Dose in Children 4 to 6 Years Old After 4 Doses of Pentacel™ or DAPTACEL® prevention 3 completed NCT00855855
Surveillance Program to Determine Product Specific Rates of Invasive Hib Disease Not Available Not Available completed NCT00315055
Immunogenicity of DTaP-IPV-Hep B-PRP~T Combined Vaccine Compared With PENTAXIM™ and ENGERIX B® at 2-3-4 Months Schedule prevention 3 completed NCT00870350
An Immunogenicity and Safety Study of Tetanus, Diphtheria and Acellular Pertussis Vaccine Booster No drug interventions basic_science 4 unknown_status NCT00258908
Immunogenicity and Safety of ADACEL™ as Fifth Dose in Taiwan prevention 3 completed NCT00158808
Immune Memory Foll Pry Vaccination With DTPw-HBV/Hib Vaccine Formulation; Immuno & Reacto of Booster Dose at 15-18 Mths prevention 2 completed NCT00674908
Phase IV Interchangeability Study of a Liquid Pentavalent Combination Vaccine No drug interventions prevention 4 completed NCT01457508
Immunogenicity and Reactogenicity of DTPa-HBV-IPV/Hib, Compared to DTPa-HBV-IPV and Hib Administered Separately prevention 3 completed NCT04099303
Phase I Clinical Trial of Diphtheria, Tetanus and Acellular Pertussis (Three Components) Combined Vaccine, Adsorbed . prevention 1 completed NCT00804284
Database Surveillance Safety Study of PENTACEL® Vaccine Not Available Not Available completed NCT02759354
Long-term Persistence of Hepatitis B and Pertussis Antibody Responses in Healthy 4 to 5 Year Old Children Previously Vaccinated With Vaxelis® or INFANRIX® Hexa (V419-012) No drug interventions prevention 3 completed NCT00404651
Lot Consistency Study of DTaP-IPV-HB-PRP~T Vaccine Administered at 2-4-6 Months of Age in Healthy Infants prevention 3 completed NCT00831753
Study of DTaP-IPV-Hep B-PRP~T Combined Vaccine Compared to Infanrix®Hexa in Healthy Peruvian Infants prevention 3 completed NCT04779853
Seroprevalence of Pertussis Among Healthy Children and Adolescents in Kazakhstan No drug interventions Not Available Not Available unknown_status NCT02089347
Study of SP306 Given Intramuscularly Compared to DT Given Subcutaneously in Japanese Adolescents 11 - 12 Years Old prevention 3 completed NCT01890447
Assessing Contacts' Decision Making on Reducing the Risk of Pertussis Transmission to Newborns Through Immunisation No drug interventions Not Available Not Available completed NCT00133445
Pentavalent DTaP-Hep B-IPV No drug interventions prevention 2 completed NCT01529645
Safety and Dose Ranging Study of Acellular Pertussis and Acellular Pertussis -Tetanus-Diphtheria Booster Vaccines in Healthy Adults Ages 18 to 40 Years prevention 1 completed NCT01711645
Tdap Vaccine in Post-Partum Women prevention 4 completed NCT03697798
A Study Exploring Whooping Cough Protection in Children and Adults prevention 4 completed NCT04535505
Pathogenic Bordetella Rapid Detection No drug interventions Not Available Not Available withdrawn NCT00772928
Study of the Effect of Pneumococcal Conjugate Vaccine (PCV) on Immunogenicity of Pentacel™ prevention 3 completed NCT00831311
Study of DTaP-IPV-Hep B-PRP~T Combined Vaccine Compared With PENTAXIM™ and ENGERIX B® PEDIATRICO in Argentinean Infants prevention 2 completed NCT00797511
Immunogenicity and Safety of Adacel Polio Vaccine prevention 3 completed NCT00313911
Safety of DTaP-IPV-Hep B-PRP~T Combined Vaccine Compared to Tritanrix-HepB/Hib™ and OPV Given at Age 2, 4, and 6 Months. prevention 3 completed NCT01346293
Study of DTap-IPV Compared to DAPTACEL® and IPOL® as the 5th Dose in Children 4 to 6 Years of Age prevention 3 completed NCT00013871
Pneumococcal Vaccine and Routine Pediatric Immunizations in HIV-Infected Children Receiving Anti-HIV Drugs prevention Not Available completed NCT01979588
How Does the Clinical Tool 'What's Going Around' Affect Clinical Practice No drug interventions diagnostic Not Available completed NCT06286007
Prevalence and Impact of Pertussis and RSV on Asthma Severity and Control No drug interventions Not Available Not Available recruiting NCT00514709
Immunogenicity Study of Antibody Persistence and Booster Effect of DTaP-HB PRP~T Combined Vaccine in Filipino Infants prevention 3 completed NCT04177485
Evaluating a Caregiver SMS Reminder Intervention to Reduce Immunization Drop-out in Arua, Uganda No drug interventions prevention Not Available completed NCT00259337
Immunogenicity and Safety of Pentaxim™ in an Indian Population prevention 3 completed NCT00004800
Phase III Randomized, Double-Blind, Placebo-Controlled Study of Acellular and Whole-Cell Pertussis Vaccines prevention 3 completed NCT00514059
Immunogenicity and Safety Study of a Booster Dose (5th) of Diphteria-Tetanus-Pertussis-Polio Vaccine No drug interventions prevention 4 completed NCT01761799
Protecting Pregnant Women From Infectious Diseases No drug interventions health_services_research Not Available completed NCT03942406
Study of BPZE1 Intranasal Pertussis Vaccine (Administered Via VaxINator(TM)), Prime + Boost, in Healthy Adults prevention 2 completed NCT01287949
Safety and Immunogenicity Study of a Diphtheria, Tetanus, Acellular Pertussis and Poliomyelitis Vaccine (REPEVAX) Followed by 2 Doses of a Diphtheria, Tetanus and Poliomyelitis Vaccine (REVAXIS) in Subjects of 40 Years of Age or Older prevention 3 completed NCT00362336
Comparison of DTaP-IPV-Hep B-PRP~T Combined Vaccine to CombAct-HIB® Concomitantly Given With Engerix B® Paediatric and OPV prevention 3 completed NCT02014519
A Study to Determine the Seroprevalence of Bordetella Pertussis in Adults in Hungary No drug interventions other Not Available completed NCT00254917
Assessment of the Immunogenicity and Safety of PENTAXIM™ in Philippines prevention 4 completed NCT01362517
Study of Quinvaxem for Vaccination Against Diphtheria, Pertussis, Tetanus, Hepatitis B and Diseases Caused by Haemophilus Influenzae Type B No drug interventions treatment 3 completed NCT05193734
Safety and Immunogenicity of 2 Doses Versus 1 Dose of Acellular Pertussis Vaccines Containing Genetically-detoxified Pertussis Toxin in Young Adults Previously Primed With Acellular Pertussis Vaccines prevention 2 / 3 unknown_status NCT01689324
Study of Tetanus Toxoid, Reduced Diphtheria Toxoid and Acellular Pertussis Vaccine (ADACEL®) as a Booster in Adolescents prevention 1 / 2 completed NCT05856396
Maternal Determinants of Infant Immunity to Pertussis basic_science 4 recruiting NCT05952596
A Study to Evaluate Safety and Immunogenicity of APV006 in Healthy Adults No drug interventions prevention 1 not_yet_recruiting NCT01137435
Post Marketing Surveillance for ADACEL™ in South Korea prevention 4 completed NCT01878435
Randomized Controlled Trial of the Impact of Mobile Phone Delivered Reminders and Travel Subsidies to Improve Childhood Immunization Coverage Rates and Timeliness in Western Kenya No drug interventions other Not Available completed NCT03950986
Increasing Vaccine Uptake Among Veterans at the Atlanta VA Health Care System No drug interventions prevention Not Available completed NCT00004422
Intravenous Pertussis Immune Globulin in Patients With Severe Childhood Pertussis Infection No drug interventions treatment 3 completed NCT01984125
Testing the Use of Prompts to Increase Adolescent Immunization Rates No drug interventions health_services_research Not Available completed NCT04694430
A Multi-center Study to Determine the Prevalence and Influence of Pertussis on COPD Exacerbation in Shenzhen No drug interventions Not Available Not Available unknown_status NCT00877357
Safety, Long Term Immunogenicity and Lot Consistency Study of Liquid Pentavalent Combination Vaccine No drug interventions prevention 4 unknown_status NCT01917357
A Comparison of the Immunogenicity and Safety of Quinvaxem in Mono-dose Vials and Uniject No drug interventions prevention 3 completed NCT01439165
Safety and Immunogenicity in Adults of Revaccination With Adacel® Vaccine 10 Years After a Previous Dose prevention 4 completed NCT00469274
Vanderbilt Pertussis Exposure Study: PEP in Vaccinated Healthcare Workers Following Pertussis Exposure No drug interventions prevention Not Available completed NCT02587520
Study of Tetanus Toxoid, Reduced Diphtheria Toxoid, and Acellular Pertussis Vaccine Adsorbed in Healthy Subjects prevention 1 / 2 completed NCT01003431
A Study of the Immunogenicity and Safety of Whole-Cell Pertussis Containing Vaccine Administered Concomitantly With RotaTeq™ (V260) or Rotarix™ (V260-036)(WITHDRAWN) prevention 3 withdrawn NCT01993173
Sanofi Pasteur's Tdap Combined Vaccine as a Booster Versus Local DT Vaccine in Children or Versus Local Td Vaccine in Adolescents and Adults in China. prevention 3 completed NCT00362427
Study of PR5I, a Pediatric Combination Vaccine With Enhanced Hepatitis B Component Given Concomitantly With Prevnar® prevention 2 completed NCT02511327
Pertussis Immunization During Pregnancy: Effect in Term and Preterm Infants No drug interventions Not Available Not Available unknown_status NCT02428491
Immunogenicity and Safety of Sanofi Pasteur's Combined Vaccine Given as a Three-Dose Primary Series at 2, 3,4 Months of Age and Followed by a Booster Dose Given at 16 to 17 Months of Age in Vietnamese Infants Who Previously Received a Dose of Hepatitis B Vaccine at Birth or Within 1 Week After Birth prevention 3 completed NCT01129362
Rates of Pertussis Disease Among Persons Receiving Pentacel® or Other Pertussis Vaccines Not Available Not Available completed NCT04023929
Sources of COmplement in Meningococcal and Pertussis Serum Bactericidal Antibody Assays No drug interventions Not Available Not Available unknown_status NCT01214889
Study of PENTAXIM™ Vaccine Versus TETRAXIM™ Vaccine Given With ACTHIB™ Vaccine in South Korean Infants. prevention 3 completed NCT04618640
To Evaluate the Immunogenicity and Safety of DTaP-IPV Vaccine Administered as a Boosting Dose to Healthy Children of 4-6 Years No drug interventions prevention 3 unknown_status NCT03208101
A Study to Compare LBVD to Eupenta and Imovax Polio in Healthy Adults No drug interventions prevention 1 completed NCT00138268
Pilot Study Freeze and Transport Immune Cells No drug interventions Not Available Not Available completed NCT03589768
Study on the Safety and Immunogenicity of Boostrix Vaccine in Pregnant Malian Women and Their Infants prevention 2 completed NCT00092469
Study of an Investigational Vaccine in Healthy Infants in Taiwan (V441-001)(COMPLETED) prevention 3 completed NCT00772369
Retrospective Survey of Safety of Fourth Dose Pentacel® in Children No drug interventions Not Available Not Available completed NCT01698346
Pertussis (Tdap) Vaccination in Pregnancy prevention 4 completed NCT04589312
Maternal Pertussis Wholecell Responses prevention 2 completed NCT02477995
Study of Adsorption Tetanus-diphtheria-acellular Pertussis (DTaP) Vaccine in Healthy 3 to 5 Months Infants No drug interventions prevention 3 completed NCT01457495
Immunogenicity and Safety of DTPa-HBV-IPV/Hib Compared to DTPa-IPV/Hib and HBV Administered Concomitantly prevention 2 completed NCT03341195
Mobile Phone SMS Messages and Automated Calls in Improving Vaccine Coverage Among Children in Pakistan No drug interventions prevention Not Available unknown_status NCT03084614
CD8 Reactivity to Microorganisms in Blood and Breast Milk No drug interventions Not Available Not Available terminated NCT04113655
2-year Follow-up After a Single Dose Acellular Pertussis Vaccination Not Available Not Available completed NCT00828555
Effectiveness of a Vaccination Program in the Community Ob/Gyn Setting No drug interventions Not Available Not Available completed NCT06056050
A Clinical Trial of Adsorbed Cell-free DPT Vaccine (5-component) (for People Aged 6 Years and Above) No drug interventions prevention 1 recruiting NCT02209623
TDAP Safety in Pregnant Women No drug interventions Not Available Not Available completed NCT01437423
Regulatory Post-Marketing Surveillance Study for TETRAXIM™ prevention 4 completed